Medicus Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8.71	4.16	1.72	0.27	0.08
Cash & Short-Term Investments	8.71	4.16	1.72	0.27	0.08
Cash Growth	109.04%	142.21%	542.38%	240.90%	-
Prepaid Expenses	0.68	0.76	0.17	0.02	-
Other Current Assets	0.51	0.46	-	-	-
Total Current Assets	9.89	5.38	1.89	0.28	0.08
Property, Plant & Equipment	0.17	0.27	-	-	-
Total Assets	10.06	5.65	1.89	0.28	0.08
Accounts Payable	3.44	1.28	0.21	0.1	0.16
Accrued Expenses	1.11	0.91	0.4	-	-
Short-Term Debt	5.25	-	0.17	1.53	0.67
Current Portion of Leases	0.15	0.12	-	-	-
Other Current Liabilities	-	-	-	10.85	9.75
Total Current Liabilities	9.94	2.31	0.78	12.48	10.58
Long-Term Debt	0.03	-	-	-	-
Long-Term Leases	0.06	0.21	-	-	-
Total Liabilities	10.02	2.51	0.78	12.48	10.58
Common Stock	57.08	30.52	18.76	0.19	0.19
Additional Paid-In Capital	6.88	1.52	0.1	-	-
Retained Earnings	-64.35	-28.9	-17.75	-12.39	-10.7
Comprehensive Income & Other	0.32	-	-	-	-
Total Common Equity	-0.07	3.13	1.11	-12.2	-10.51
Minority Interest	0.1	-	-	-	-
Shareholders' Equity	0.04	3.13	1.11	-12.2	-10.51
Total Liabilities & Equity	10.06	5.65	1.89	0.28	0.08
Total Debt	5.48	0.32	0.17	1.53	0.67
Net Cash (Debt)	3.23	3.84	1.55	-1.26	-0.59
Net Cash Growth	-15.98%	147.33%	-	-	-
Net Cash Per Share	0.19	0.40	0.45	-0.67	-0.18
Filing Date Shares Outstanding	39.36	11.82	8.08	6.43	3.22
Total Common Shares Outstanding	25.18	11.82	8.08	6.43	3.22
Working Capital	-0.05	3.07	1.11	-12.2	-10.51
Book Value Per Share	-0.00	0.27	0.14	-1.90	-3.27
Tangible Book Value	-0.07	3.13	1.11	-12.2	-10.51
Tangible Book Value Per Share	-0.00	0.27	0.14	-1.90	-3.27

Source: S&P Capital IQ. Standard template. Financial Sources.